Related Experiment Video
Updated: Feb 2, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Hyperhomocysteinemia as a risk factor for cardiovascular disease in patients undergoing hemodialysis
1New England Medical Center, Boston, MA, USA.
Insights
High homocysteine levels are common in kidney disease patients and may increase cardiovascular risk. Folic acid can lower, but not eliminate, these levels, with ongoing research into its impact on heart health.
Area of Science:
- Nephrology
- Cardiology
- Nutritional Science
Background:
- Hyperhomocysteinemia is prevalent in end-stage renal disease (ESRD) and dialysis patients.
- Elevated homocysteine is a potential risk factor for cardiovascular disease (CVD) in this population.
Purpose of the Study:
- To investigate the role of hyperhomocysteinemia in cardiovascular risk among renal disease patients.
- To evaluate the efficacy of folic acid supplementation in managing hyperhomocysteinemia in dialysis patients.
Main Methods:
- Observational analysis of homocysteine levels in ESRD and dialysis patients.
- Assessment of folic acid's impact on homocysteine concentrations.
Main Results:
- Hyperhomocysteinemia is confirmed in patients with end-stage renal disease and those on dialysis.
- Folic acid supplementation demonstrates a capacity to reduce, though not fully normalize, homocysteine levels.
Conclusions:
- Hyperhomocysteinemia is a significant finding in renal disease patients, potentially contributing to CVD.
- Folic acid offers partial correction of hyperhomocysteinemia, but further evidence is needed to confirm its cardiovascular benefits.
Abstract:
Hyperhomocysteinemia exists among patients both in end-stage renal disease and on dialysis and may represent an additional risk factor for increased cardiovascular disease. Supplementation with folic acid may reduce, but not correct, hyperhomocysteinemia. Evidence that lowering blood homocysteine will lessen cardiovascular risk is being sought.
More Related Videos
04:36Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...